The Two Organs That Suffer Most from Diabetes
Diabetic kidney disease (DKD) is the leading cause of kidney failure in the Philippines — and the world. Approximately 1 in 3 people with Type 2 diabetes will develop significant kidney involvement. The insidious part: kidney damage begins years before any symptoms appear. This guide helps you understand the process, recognize warning signs, and take control.
Why does diabetes harm kidneys?
Chronically elevated blood sugar damages the delicate filtration membrane of the kidney. This leads to protein leakage, scarring, and progressive loss of filtering units — a process that unfolds silently over 10–15 years.
The good news
DKD is one of the most preventable forms of kidney disease. With tight glucose control, blood pressure management, and the right medications, progression can be dramatically slowed — or even halted.
How High Blood Sugar Damages the Kidney — Step by Step
Understanding the mechanism helps you appreciate why every intervention your doctor recommends matters.
Glucose overloads the glomerular filtration membrane
Excess glucose activates multiple harmful pathways: advanced glycation end-products (AGEs), oxidative stress, and activation of protein kinase C — all of which directly damage the glomerular basement membrane and podocytes (the specialized cells that form the filtration barrier).
Blood vessels inside the kidney become hyper-pressurized
Diabetes causes dilation of the afferent arteriole (inlet vessel) and constriction of the efferent arteriole (outlet) — dramatically raising pressure inside the glomerulus. This "hyperfiltration" accelerates structural damage and is a target for ACE inhibitors and SGLT2 inhibitors.
Protein starts leaking into urine — the first detectable sign
As the filtration membrane breaks down, albumin leaks through. Microalbuminuria (30–300 mg/g UACR) is the earliest detectable sign — often present years before eGFR declines. Detecting this early is why annual urine testing is essential for all diabetic patients.
Scarring and loss of filtering units
Sustained injury triggers TGF-β–driven fibrosis — progressive replacement of functional glomeruli with scar tissue. Once sclerosis is established, it is irreversible. Each scarred nephron is permanently lost. This is why early intervention is so critical.
Kidney failure requiring dialysis or transplant
When >85–90% of nephrons are lost, the kidneys can no longer sustain life. Renal replacement therapy becomes necessary. This stage is preventable in the vast majority of cases with early, consistent treatment.
What Is HbA1c — and Why Does It Matter for Your Kidneys?
HbA1c (glycated hemoglobin) reflects your average blood sugar over the past 2–3 months. Think of it this way: sugar in the bloodstream naturally attaches itself to hemoglobin — the protein inside red blood cells that carries oxygen. Since red blood cells live approximately 90 days, HbA1c tells us how much sugar has been "sticking" over that period.
Why does sugar "linger" in the bloodstream?
In diabetes, the door that lets sugar into cells (controlled by insulin) is either missing or stuck. Sugar builds up in the blood because it cannot get where it needs to go. This lingering sugar is what damages kidneys, blood vessels, nerves, and eyes over time.
HbA1c ranges and what they mean
Why 7–8% (not <7%) for CKD patients?
Tighter control (HbA1c <7%) increases hypoglycemia risk — which is dangerous when the kidneys cannot clear certain medications efficiently. For most CKD patients, a target of 7–8% balances glucose control with safety. Your doctor will individualize this for you.
Stages of Diabetic Kidney Disease
DKD is classified by both eGFR and the amount of albumin in the urine. The combination determines your risk category and guides treatment intensity.
| Stage | eGFR | Urine Albumin (UACR) | Clinical Significance |
|---|---|---|---|
| Hyperfiltration phase | > 125 mL/min | Normal | Glomerular hypertension begins — no detectable damage yet. Blood pressure and glucose control critical here. |
| Early DKD | 60–90 mL/min | Microalbuminuria: 30–300 mg/g | First detectable sign of damage. RAAS blockade (ACE/ARB) + SGLT2 inhibitor strongly indicated. |
| Established DKD | 30–60 mL/min | Macroalbuminuria: > 300 mg/g | Significant scarring present. Dose-adjust medications; monitor electrolytes; consider finerenone. |
| Advanced DKD | 15–29 mL/min | Variable (may decline as nephrons lost) | Prepare for renal replacement therapy. Nephrologist-led care essential. |
| Kidney failure (ESKD) | < 15 mL/min | Variable | Dialysis or transplant required. Ongoing diabetes management continues. |
What Needs Monitoring — and How Often
All patients with diabetes and kidney disease require structured, regular laboratory surveillance. Missing even one monitoring cycle can delay detection of potentially reversible deterioration.
Creatinine + eGFR
Measures current kidney filtering capacity. The trend over time is more informative than a single value.
Every 3–6 months (or per nephrologist)Urine UACR
Albumin-to-creatinine ratio — the earliest and most sensitive marker of diabetic kidney damage.
Every 6–12 monthsHbA1c
3-month average blood glucose. Target 7–8% for most CKD patients. Test more frequently if adjusting medications.
Every 3 monthsElectrolytes (K, Na, HCO₃)
Potassium rises as kidneys decline. Bicarbonate falls with metabolic acidosis. RAAS blockers require close monitoring.
Every 1–3 monthsBlood pressure
Target < 140/90 mmHg. Optimal BP control is among the most powerful interventions to slow DKD.
Every visit; home monitoring encouragedCBC + Ferritin/TSAT
Anemia develops as eGFR falls. Iron stores must be adequate before erythropoiesis-stimulating agents are used.
Every 3–6 months (Stage 3+)Calcium, Phosphorus, PTH
Mineral bone disorder begins at Stage 3. Elevated phosphorus drives vascular calcification and cardiovascular risk.
Every 3–6 months (Stage 3b+)Lipid panel + LDL
CKD + diabetes = very high ASCVD risk. LDL target <55 mg/dL per 2026 ACC/AHA guidelines.
Annually (or per adjustment)Key Medications That Protect Kidneys in Diabetes
Modern diabetes management goes far beyond glucose control. Several medication classes now have strong evidence for direct kidney and cardiovascular protection — independent of their glucose-lowering effect.
Finerenone — the newest kidney protector
Finerenone (a non-steroidal mineralocorticoid receptor antagonist) has recently been approved for DKD. The FIDELIO-DKD and FIGARO-DKD trials demonstrated significant reductions in proteinuria and kidney progression. It is used add-on to ACE/ARB + SGLT2i for high-risk DKD patients. Ask your doctor if this is appropriate for you.
Medications to avoid or adjust in CKD + Diabetes
- Metformin: Safe until eGFR <30; hold during contrast studies or acute illness
- NSAIDs (ibuprofen, mefenamic acid): Avoid entirely — nephrotoxic and worsen fluid retention
- Sulfonylurreas (glibenclamide): High hypoglycemia risk as kidneys decline; switch to shorter-acting options
- Contrast dye: Always inform radiology of CKD; ensure adequate hydration
Your Goal Numbers
| Parameter | Target | Why it matters |
|---|---|---|
| HbA1c | 7–8% (CKD patients) | Prevents further hyperglycemic damage without excess hypoglycemia risk |
| Blood pressure | < 140/90 mmHg | Reducing BP slows proteinuria progression independently of glucose |
| LDL cholesterol | < 55 mg/dL | CKD + DM = very high ASCVD risk. Aggressive lipid lowering reduces event rates significantly |
| UACR (urine protein) | Reduce by ≥ 30% | Declining proteinuria indicates treatment is working and slowing scarring |
| eGFR trend | Stable or <3 mL/min/yr decline | A rapid drop (>5 mL/min/yr) signals inadequate control or acute superimposed injury |
| Potassium | 3.5–5.5 mEq/L | Hyperkalemia risk from CKD + RAAS blockade; high K causes life-threatening arrhythmias |
| Hemoglobin | 100–115 g/L | Anemia worsens cardiac strain; ESA therapy initiated when below target |
| Fasting glucose | 80–130 mg/dL | Day-to-day glucose control; hypoglycemia below 70 requires action |
Lifestyle Strategies That Protect Kidneys
Carbohydrate quality over quantity
Choose complex, low-glycemic carbohydrates — brown rice, kamote, sayote, ampalaya. Avoid sweetened beverages, instant foods, and white bread. A consistent eating schedule prevents glucose spikes that damage glomeruli.
Protein — the right amount
Pre-dialysis CKD: target 0.6–0.8 g/kg/day. Excess protein increases glomerular filtration pressure and accelerates scarring. Choose fish, egg whites, and lean chicken over red meat and organ meats.
Sodium restriction
Limit to <2,000 mg/day (about 1 teaspoon of salt). Salt raises blood pressure and worsens proteinuria directly — independent of medication. Avoid bagoong, soy sauce, instant noodles, and processed foods.
Physical activity
150 minutes per week of moderate activity (brisk walking, swimming, cycling) improves insulin sensitivity, lowers blood pressure, and reduces cardiovascular risk. Even 30 minutes daily significantly benefits kidney-related outcomes.
Weight management
Each kilogram of excess weight adds to insulin resistance and glomerular hyperfiltration. A 5–10% reduction in body weight significantly improves HbA1c, blood pressure, and proteinuria simultaneously.
Stop smoking, limit alcohol
Smoking accelerates kidney disease progression through endothelial damage and ischemia. Alcohol disrupts glucose control and raises blood pressure. Both are independently associated with faster CKD decline.
Kidney-friendly Filipino foods for diabetics
- Ampalaya (bitter melon) — natural insulin sensitizer; low potassium, low phosphorus
- Sayote — low calorie, low potassium, high fiber; excellent for glucose control
- Bangus (milkfish) / tilapia — high-quality protein; omega-3 content reduces inflammation
- Kangkong / pechay — low potassium after boiling; excellent micronutrient density
- Egg whites — high biological value protein with minimal phosphorus
- Kamote (purple variety) — glycemic index lower than white potato; moderate potassium (leach before eating)
When to Seek Immediate Medical Attention
⚠ Go to the ER or call your doctor immediately if you experience:
Frequently Asked Questions
My blood sugar is now controlled. Will my kidneys recover?
Achieving good glucose control can slow or halt further kidney damage — and may even partially reduce proteinuria. However, scar tissue (glomerulosclerosis) that has already formed does not reverse. This is why early detection and treatment are so important. The earlier you control diabetes, the more kidney tissue is preserved.
Is dialysis inevitable if I have diabetic kidney disease?
No — not inevitably. With consistent treatment of blood pressure, glucose, and proteinuria, many patients with DKD remain off dialysis for the remainder of their natural lives. Kidney failure is the worst outcome on a spectrum — most patients can be kept well away from it with modern therapy and diligent follow-up.
My creatinine went up slightly after starting my ACE inhibitor. Should I stop it?
Not necessarily — a rise in creatinine of up to 30% from baseline in the first 2 weeks after starting an ACE inhibitor or ARB is expected and acceptable. This reflects reduced intraglomerular pressure (a beneficial effect), not true kidney worsening. However, if creatinine rises sharply or potassium rises above 5.5, contact your doctor.
Can I take metformin with kidney disease?
Metformin is safe and beneficial when eGFR is above 45 mL/min. It should be used with caution between 30–45, and stopped below 30. It must also be held 48 hours before iodinated contrast procedures. Your doctor will advise whether and when to discontinue it based on your lab trend.
W. G. M. Rivero, MD, FPCP, DPSN
Specialist in Internal Medicine, Nephrology, and Clinical Nutrition. Practicing integrative and evidence-based nephrology across Quezon City, Pampanga, and Bulacan.
PRC 0105184 · seriousmd.com/doc/williamrivero · williamrivero@gmail.com